CRISPR

CRISPR1-sirt1

ID
ZDB-CRISPR-201105-1
Name
CRISPR1-sirt1
Previous Names
None
Target
Sequence
5' - ACGAGAAACCGGCGCGGA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The PAM site was "TGG" at the 3' end.
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
yu28 sirt1
Expression
Gene expression in Wild Types + CRISPR1-sirt1
No data available
Phenotype
Phenotype resulting from CRISPR1-sirt1
No data available
Phenotype of all Fish created by or utilizing CRISPR1-sirt1
Phenotype Fish Conditions Figures
intestine atrophied, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 4 with image from Kim et al., 2019
whole organism socs1a expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
whole organism nfe2l2a expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
inflammatory response increased process quality, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
reactive oxygen species biosynthetic process occurrence, ameliorated sirt1yu28/yu28 (AB) chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
reactive oxygen species biosynthetic process increased occurrence, abnormal sirt1yu28/yu28 (AB) control Fig. 2 with image from Kim et al., 2019
reactive oxygen species biosynthetic process increased occurrence, exacerbated sirt1yu28/yu28 (AB) chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
whole organism decreased life span, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 5 with image from Kim et al., 2019
apoptotic process increased occurrence, abnormal sirt1yu28/yu28 (AB) control Fig. 2 with image from Kim et al., 2019
whole organism casp3a expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
whole organism sirt1 expression absent, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 1 with image from Kim et al., 2019
pancreas inflammatory response increased occurrence, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 4 with image from Kim et al., 2019
spleen inflammatory response increased occurrence, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 4 with image from Kim et al., 2019
whole organism il6 expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
apoptotic process increased occurrence, exacerbated sirt1yu28/yu28 (AB) chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
whole organism viability, ameliorated sirt1yu28/yu28 (AB) chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
whole organism socs3a expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
intestine tnfa expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 5 with image from Kim et al., 2019
apoptotic process occurrence, ameliorated sirt1yu28/yu28 (AB) chemical treatment by environment: N-acetyl-L-cysteine, chemical treatment by environment: tert-butyl hydroperoxide Fig. 2 with image from Kim et al., 2019
intestine apoptotic process increased occurrence, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 5 with image from Kim et al., 2019
whole organism tnfa expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
intestine inflamed, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 4 with image from Kim et al., 2019
intestine rela expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 5 with image from Kim et al., 2019
pancreas inflamed, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 4 with image from Kim et al., 2019
whole organism tgfb1a expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
spleen inflamed, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 4 with image from Kim et al., 2019
intestine mpx expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 5 with image from Kim et al., 2019
intestine inflammatory response increased occurrence, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 4 with imageFig. 5 with image from Kim et al., 2019
whole organism il1b expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
whole organism nos2a expression increased amount, abnormal sirt1yu28/yu28 (AB) standard conditions Fig. 3 with image from Kim et al., 2019
Citations